HUMANA INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 347.4 USD | +0.60% |
|
-1.15% | -23.95% |
| 12:09pm | Baird Initiates Humana at Neutral Rating With $374 Price Target | MT |
| 05-29 | US health insurer shares fall after UnitedHealth flags Medicaid medical use | RE |
Humana Inc. is one of the leading health insurance and complementary medical services companies in the United States. Revenues break down by activity as follows:
- health insurance services (95.2%): to recipients of government-sponsored plans, to groups of employers and individuals;
- services (3.8%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical services, etc.;
- other (1%).
Sector
Managed Healthcare
Calendar
27/06/2024
- Ex-dividend day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
345.3
USD
Average target price
369.5
USD
Spread / Average Target
+7.00%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -23.95% | 41.61B | |
| -8.69% | 446B | |
| +6.87% | 117B | |
| +10.96% | 94.57B | |
| -13.77% | 18.46B | |
| -29.57% | 2.5B | |
| -7.72% | 1.33B | |
| +17.11% | 511M |
- Stock Market
- Equities
- HUM Stock
- News Humana Inc.
- Credit Suisse Adjusts Humana's Price Target to $513 from $500, Keeps Outperform Rating
